AVTE: Aerovate Therapeutics, Inc. Stock

by  •  • Comments Off on AVTE: Aerovate Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 74.50
Enterprise Value ($M) 43.38
Book Value ($M) 80.49
Book Value / Share 2.79
Price / Book 0.93
NCAV ($M) 80.14
NCAV / Share 2.78
Price / NCAV 0.93

Profitability (mra)
Return on Invested Capital (ROIC) -1.04
Return on Assets (ROA) -0.66
Return on Equity (ROE) -0.77

Liquidity (mrq)
Quick Ratio 8.78
Current Ratio 8.78

Balance Sheet (mrq) ($M)
Current Assets 90.61
Assets 90.96
Liabilities 10.47
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Baker Bros. Advisors Lp 2.20 -62.57
06-20 13D/A Ra Capital Management, L.p. 32.00 11.16
02-20 13D/A Sofinnova Venture Partners X, L.P. 13.80 0.63
02-14 13G/A Cormorant Asset Management, LP 4.38 -38.09
02-14 13G/A Citadel Advisors Llc 0.00
02-09 13G TCG Crossover GP I, LLC 8.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-21 131,597 310,850 42.33
2025-01-17 55,170 183,283 30.10
2025-01-16 37,385 96,251 38.84

(click for more detail)

Similar Companies
AURA – Aura Biosciences, Inc. AVBP – ArriVent BioPharma, Inc.
AVDL – Avadel Pharmaceuticals plc AXSM – Axsome Therapeutics, Inc.
BCAB – BioAtla, Inc.


Financial data and stock pages provided by
Fintel.io